TY - JOUR
T1 - Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor
T2 - results from 8 years' surveillance in the Danish nationwide DANBIO registry
AU - Glintborg, Bente
AU - Østergaard, Mikkel
AU - Krogh, Niels Steen
AU - Dreyer, Lene
AU - Kristensen, Hanne Lene
AU - Hetland, Merete Lund
PY - 2010
Y1 - 2010
N2 - To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor α (TNFα) inhibitor.
AB - To use prospectively registered data from the Danish nationwide rheumatological database (DANBIO) to describe disease activity, clinical response, treatment duration and predictors of drug survival (ie, number of days individual patients maintained treatment) and clinical response among patients with ankylosing spondylitis (AS) receiving their first treatment series with a tumour necrosis factor α (TNFα) inhibitor.
U2 - 10.1136/ard.2009.124446
DO - 10.1136/ard.2009.124446
M3 - Journal article
SN - 0003-4967
VL - 69
SP - 2002
EP - 2008
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 11
ER -